SEC 13F Intelligence

Managers / Q1 2025 · view latest →

Sivik Global Healthcare LLC

CIK 0001596452 · 133 TACONIC RD, GREENWICH, CT, 06831 · 203-769-8600

Reported Value
$185M
Q1 2025
Positions
31
Filings on Record
30
2019–present window
Filed
Apr 22, 2025
original filing

Summary

Sivik Global Healthcare LLC reported $185M in U.S.-listed holdings across 31 positions for Q1 2025.

Its largest position, XBI, represents 11.0% of the portfolio.

Compared with Q4 2024, the fund opened 6 new positions and exited 13.

Portfolio Metrics

Turnover
+23.3%
vs prior filed quarter
Top-10 Concentration
+49.3%
share of reported value
Largest Position
+11.0%
Spdr S P Biotech Etf
New / Exited
6 / 13
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $186MQ4 ’18Q1 ’19: $271MQ2 ’19: $414MQ3 ’19: $198MQ4 ’19: $269MQ4 ’19Q1 ’20: $253MQ2 ’20: $302MQ3 ’20: $232MQ4 ’20: $245MQ4 ’20Q1 ’21: $274MQ2 ’21: $512MQ3 ’21: $419MQ4 ’21: $233MQ4 ’21Q1 ’22: $242MQ2 ’22: $176MQ3 ’22: $180MQ4 ’22: $213MQ4 ’22Q1 ’23: $233MQ2 ’23: $428MQ3 ’23: $198MQ4 ’23: $239MQ4 ’23Q1 ’24: $427MQ2 ’24: $278MQ3 ’24: $236MQ4 ’24: $190MQ4 ’24Q1 ’25: $185MQ2 ’25: $368MQ3 ’25: $344MQ4 ’25: $345MQ4 ’25Q1 ’26: $132Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 81.4%ETP: 11.0%ADR: 7.3%Other: 0.4%
  • Common Stock · 81.4% · $151M
  • ETP · 11.0% · $20M
  • ADR · 7.3% · $13M
  • Other · 0.4% · $755,000

Quarter-over-Quarter Changes full breakdown →

vs Q4 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
MDTMEDTRONIC INCNEW+75.0K75.0K+$7M$7M
BAXBAXTER INTERNATIONAL INC.NEW+175.0K175.0K+$6M$6M
AZNNASTRAZENECA PLC-SPONS ADRNEW+70.0K70.0K+$5M$5M
GILDGILEAD SCIENCES INCNEW+40.0K40.0K+$4M$4M
WSTWEST PHARMACEUTICAL SERVICES INCNEW+12.5K12.5K+$3M$3M
PUT - SPY 100 @ 570 EXP 04/17/2025NEW+500500+$755,000$755,000
VRTXVERTEX PHARMACEUTICALS INC.SOLD OUT−13.0K0−$5M$0
ABBVABBVIE INCSOLD OUT−25.0K0−$4M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2025

29 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1XBISPDR S&P BIOTECH ETFhistory →S&P BIOTECH10.96%$20M250.0K
2BSXBOSTON SCIENTIFIC CORPORATIONhistory →COM5.45%$10M100.0K
3THCTENET HEALTHCAREhistory →COM NEW5.09%$9M70.0K
4HCAHCA HEALTHCARE INChistory →COM4.67%$9M25.0K
5LLYELI LILLY & COhistory →COM4.02%$7M9.0K
6MCKMCKESSON CORPhistory →COM4.00%$7M11.0K
7DHRDANAHER CORPhistory →COM3.88%$7M35.0K
8CORCENCORA INChistory →COM3.76%$7M25.0K
9ISRGINTUITIVE SURGhistory →COM NEW3.75%$7M14.0K
10CAHCARDINAL HEALTHhistory →COM3.72%$7M50.0K
11MDTMEDTRONIC INChistory →SHS3.64%$7M75.0K
12SYKSTRYKER CORPhistory →COM3.52%$7M17.5K
13WATWATERS CORPhistory →COM3.39%$6M17.0K
14UHSUNIV HEALTH SVChistory →CLASS B3.30%$6M32.5K
15HUMHUMANA INC.history →COM3.29%$6M23.0K
16BAXBAXTER INTERNATIONAL INC.history →COM3.24%$6M175.0K
17ABTABBOTT LABShistory →COM3.23%$6M45.0K
18AAGILENT TECHNOLOGIES INChistory →COM3.16%$6M50.0K
19EHCENCOMPASS HEALTH CORPhistory →COM2.83%$5M51.6K
20AZNNASTRAZENECA PLC-SPONS ADRhistory →SPONSORED ADR2.78%$5M70.0K
21NVONOVO-NORDISK A/Shistory →ADR2.63%$5M70.0K
22GILDGILEAD SCIENCES INChistory →COM2.42%$4M40.0K
23CICIGNA GROUP/THEhistory →COM2.22%$4M12.5K
24SNNSMITH & NEPHEWhistory →SPDN ADR NEW1.84%$3M120.0K
25S24SELECT MEDICAL HOLDINGS CORPhistory →COM1.81%$3M200.0K
26AVTRAVANTOR INChistory →COM1.75%$3M200.0K
27SGRYSURGERY PARTNERS INChistory →COM1.61%$3M125.0K
28WSTWEST PHARMACEUTICAL SERVICES INChistory →COM1.51%$3M12.5K
29UNHUNITEDHEALTH GRPhistory →COM1.42%$3M5.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$132M34Apr 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$345M49Jan 21, 202613F-HRchanges · EDGAR ↗
Q3 2025$344M44Oct 23, 202513F-HRchanges · EDGAR ↗
Q2 2025$368M46Jul 25, 202513F-HRchanges · EDGAR ↗
Q1 2025$185M31Apr 22, 202513F-HRchanges · EDGAR ↗
Q4 2024$190M38Jan 23, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M35Nov 6, 202413F-HRchanges · EDGAR ↗
Q2 2024$278M38Jul 29, 202413F-HRchanges · EDGAR ↗
Q1 2024$427M47May 1, 202413F-HRchanges · EDGAR ↗
Q4 2023$239M39Feb 5, 202413F-HRchanges · EDGAR ↗
Q3 2023$198M33Nov 7, 202313F-HRchanges · EDGAR ↗
Q2 2023$428M43Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023$233M40May 8, 202313F-HRchanges · EDGAR ↗
Q4 2022$213M39Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$180M41Nov 4, 202213F-HRchanges · EDGAR ↗
Q2 2022$176M38Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$242M49May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$233M45Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$419M43Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$512M49Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$274M47May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$245M38Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$232M38Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$302M52Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$253M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$269M50Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$198M45Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$414M62Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$271M61May 8, 201913F-HRchanges · EDGAR ↗
Q4 2018$186M48Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.